Go Pro
→ The REAL Reason Trump is Invading Iran (From Banyan Hill Publishing) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Enovis Corporation stock logo
ENOV
Enovis
$18.03
+1.3%		$24.55
$17.30
▼
$34.28
$1.03B1.311.75 million shs2.65 million shs
iRadimed Corporation stock logo
IRMD
iRadimed
$82.12
-0.7%		$89.09
$67.84
▼
$107.90
$1.06B0.89101,173 shs211,426 shs
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
$53.01
$47.81
$29.43
▼
$90.32
$2.76B-2.221.75 million shsN/A
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
$86.42
-0.3%		$83.56
$60.10
▼
$156.00
$3.00B1.9661,017 shs1.44 million shs
10 Stocks Powering The Next AI Boom Cover
10 Stocks Powering The Next AI Boom

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Enovis Corporation stock logo
ENOV
Enovis
+1.10%-7.75%-32.04%-17.87%-43.92%
iRadimed Corporation stock logo
IRMD
iRadimed
-0.75%-0.12%-6.04%-10.93%+16.05%
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
0.00%0.00%0.00%0.00%+3.98%
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
-0.28%+5.16%-8.03%+9.68%-27.87%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Enovis Corporation stock logo
ENOV
Enovis
$18.03
+1.3%		$24.55
$17.30
▼
$34.28
$1.03B1.311.75 million shs2.65 million shs
iRadimed Corporation stock logo
IRMD
iRadimed
$82.12
-0.7%		$89.09
$67.84
▼
$107.90
$1.06B0.89101,173 shs211,426 shs
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
$53.01
$47.81
$29.43
▼
$90.32
$2.76B-2.221.75 million shsN/A
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
$86.42
-0.3%		$83.56
$60.10
▼
$156.00
$3.00B1.9661,017 shs1.44 million shs
10 Stocks Powering The Next AI Boom Cover
10 Stocks Powering The Next AI Boom

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Enovis Corporation stock logo
ENOV
Enovis
+1.10%-7.75%-32.04%-17.87%-43.92%
iRadimed Corporation stock logo
IRMD
iRadimed
-0.75%-0.12%-6.04%-10.93%+16.05%
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
0.00%0.00%0.00%0.00%+3.98%
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
-0.28%+5.16%-8.03%+9.68%-27.87%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Enovis Corporation stock logo
ENOV
Enovis
2.75
Moderate Buy$40.38123.94% Upside
iRadimed Corporation stock logo
IRMD
iRadimed
3.00
Buy$120.0046.13% Upside
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
2.00
Hold$73.0037.71% Upside
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
2.33
Hold$121.1040.13% Upside

Current Analyst Ratings Breakdown

Latest IRMD, TMDX, SLNO, and ENOV Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/11/2026
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
Needham & Company LLC logo
Needham & Company LLC
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy
9/9/2026
iRadimed Corporation stock logo
IRMD
iRadimed
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold (C+) ➝ Buy (B-)
9/8/2026
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
TD Cowen logo
TD Cowen
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$120.00
9/2/2026
Enovis Corporation stock logo
ENOV
Enovis
Citigroup Inc. logo
Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingMarket Outperform
9/2/2026
Enovis Corporation stock logo
ENOV
Enovis
Wells Fargo & Company logo
Wells Fargo & Company
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetOverweight$39.00 ➝ $33.00
9/2/2026
Enovis Corporation stock logo
ENOV
Enovis
Citizens Jmp logo
Citizens Jmp
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetMarket Outperform$55.00 ➝ $47.00
9/1/2026
Enovis Corporation stock logo
ENOV
Enovis
BTIG Research logo
BTIG Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$40.00 ➝ $36.00
9/1/2026
Enovis Corporation stock logo
ENOV
Enovis
BMO Capital Markets logo
BMO Capital Markets
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$27.00
8/31/2026
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold (C-) ➝ Hold (C)
8/17/2026
Enovis Corporation stock logo
ENOV
Enovis
Canaccord Genuity Group Inc. logo
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$50.00 ➝ $45.00
8/7/2026
Enovis Corporation stock logo
ENOV
Enovis
BMO Capital Markets logo
BMO Capital Markets
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOutperform$30.00
(Data available from 9/19/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Enovis Corporation stock logo
ENOV
Enovis
$2.25B0.46$27.32 per share0.66$26.09 per share0.69
iRadimed Corporation stock logo
IRMD
iRadimed
$83.81M12.53$1.84 per share44.51$7.44 per share11.04
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
$285.01M9.69$0.43 per share124.10$9.51 per share5.57
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
$605.49M4.93$3.92 per share22.07$13.79 per share6.27
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Enovis Corporation stock logo
ENOV
Enovis
-$1.18B-$19.26N/A5.85N/A-47.96%12.03%4.91%11/5/2026 (Estimated)
iRadimed Corporation stock logo
IRMD
iRadimed
$22.48M$1.7945.88N/AN/A26.70%23.45%20.36%11/2/2026 (Estimated)
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
$20.89M$1.7729.959.89N/A33.70%22.85%18.25%N/A
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
$190.29M$3.8922.2238.241.1922.69%15.88%5.95%11/4/2026 (Estimated)

Latest IRMD, TMDX, SLNO, and ENOV Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/6/2026Q2 2026
Enovis Corporation stock logo
ENOV
Enovis
$0.8470$0.90+$0.0530-$0.02$581.84 million$582.78 million
8/4/2026Q2 2026
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
$0.4955$0.44-$0.0555$0.41$184.00 million$189.95 million
7/31/2026Q2 2026
iRadimed Corporation stock logo
IRMD
iRadimed
$0.44$0.46+$0.02$0.41$20.35 million$20.47 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Enovis Corporation stock logo
ENOV
Enovis
N/AN/AN/AN/AN/A
iRadimed Corporation stock logo
IRMD
iRadimed
$0.800.97%N/A44.69%1 Years
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
N/AN/AN/AN/AN/A
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
N/AN/AN/AN/AN/A

Latest IRMD, TMDX, SLNO, and ENOV Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/30/2026
iRadimed Corporation stock logo
IRMD
iRadimed
quarterly$0.200.92%8/14/20268/14/20268/28/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Enovis Corporation stock logo
ENOV
Enovis
0.84
1.98
1.00
iRadimed Corporation stock logo
IRMD
iRadimed
N/A
9.46
8.13
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
0.10
5.62
5.32
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
1.62
6.62
6.07

Institutional Ownership

CompanyInstitutional Ownership
Enovis Corporation stock logo
ENOV
Enovis
98.45%
iRadimed Corporation stock logo
IRMD
iRadimed
92.34%
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
97.42%
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
99.67%

Insider Ownership

CompanyInsider Ownership
Enovis Corporation stock logo
ENOV
Enovis
2.90%
iRadimed Corporation stock logo
IRMD
iRadimed
34.60%
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
6.40%
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
6.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
Enovis Corporation stock logo
ENOV
Enovis
7,80257.67 million56.00 millionOptionable
iRadimed Corporation stock logo
IRMD
iRadimed
16612.79 million8.36 millionOptionable
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
3052.12 million48.78 millionOptionable
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
89834.56 million32.18 millionOptionable

Recent News About These Companies

TransMedics Group (NASDAQ:TMDX) Shares Up 4.5% on Insider Buying Activity
September 17 at 1:20 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31027707
David Weill Acquires 1,336 Shares of TransMedics Group (NASDAQ:TMDX) Stock
September 16 at 4:38 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31027340
TransMedics Group, Inc. (TMDX) Presents at 2026 Global Healthcare Conference - Slideshow
September 15, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4946659-transmedics-group-inc-tmdx-presents-at-2026-global-healthcare-conference-slideshow
TransMedics Group (NASDAQ:TMDX) Trading Up 4.5% on Insider Buying Activity
September 15, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-transmedics-group-nasdaq-tmdx-trading-up-45-on-insider-buying-activity-2026-09-15/
2 Stocks Down 28% and 34% to Buy and Hold
September 15, 2026  |  fool.comhttps://www.fool.com/investing/2026/09/15/2-stocks-down-28-and-34-that-to-buy-and-hold/
Insider Buying: TransMedics Group (NASDAQ:TMDX) Director Purchases $109,057.68 in Stock
September 15, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-tmdx-insider-buying-and-selling-2026-09-15/
TransMedics Group, Inc. (TMDX) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
September 14, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4946220-transmedics-group-inc-tmdx-presents-at-morgan-stanley-24th-annual-global-healthcare
Insider Buying: TransMedics Group (NASDAQ:TMDX) Director Buys 1,336 Shares of Stock
September 14, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/insider-insider-buying-transmedics-group-nasdaq-tmdx-director-buys-1336-shares-of-stock-2026-09-14/
TransMedics Group Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of TransMedics Group, Inc. - TMDX
September 14, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260914420394/en/transmedics-group-investigation-initiated-kahn-swick-foti-llc-investigates-the-officers-and-directors-of-transmedics-group-inc.---tmdx/
Canaccord Genuity Keeps Their Buy Rating on TransMedics Group (TMDX)
September 12, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/markets-news/Tipranks/4572061/canaccord-genuity-keeps-their-buy-rating-on-transmedics-group-tmdx/
TransMedics Group Names New Chief Financial Officer
September 12, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/TMDX/pressreleases/4565249/transmedics-group-names-new-chief-financial-officer/
TransMedics Group (NASDAQ:TMDX) Stock Price Down 4.1% - What's Next?
September 11, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-transmedics-group-nasdaq-tmdx-stock-price-down-41-whats-next-2026-09-11/
TransMedics Group, Inc.: TransMedics Appoints Fernando Araujo as Chief Financial Officer and Reiterates 2026 Financial Outlook
September 11, 2026  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2026-09/69552894-transmedics-group-inc-transmedics-appoints-fernando-araujo-as-chief-financial-officer-and-reiterates-2026-financial-outlook-008.htm
Transmedics Names Fernando Araujo CFO, Reiterates FY26 Outlook
September 10, 2026  |  rttnews.comhttps://www.rttnews.com/3690146/transmedics-names-fernando-araujo-cfo-reiterates-fy26-outlook.aspx
TransMedics Appoints Fernando Araujo as Chief Financial Officer and Reiterates 2026 Financial Outlook
September 10, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/transmedics-appoints-fernando-araujo-as-chief-financial-officer-and-reiterates-2026-financial-outlook-302875738.html
TransMedics Group, Inc. (NASDAQ:TMDX) Receives Consensus Recommendation of "Hold" from Brokerages
September 10, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31013936
TransMedics Group, Inc. (NASDAQ:TMDX) Given Consensus Rating of "Hold" by Brokerages
September 10, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/consensus-transmedics-group-inc-nasdaq-tmdx-given-consensus-rating-of-hold-by-brokerages-2026-09-10/
TD Cowen Reaffirms "Buy" Rating for TransMedics Group (NASDAQ:TMDX)
September 10, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31013703
TransMedics Group's (TMDX) "Buy" Rating Reiterated at TD Cowen
September 8, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/analyst-transmedics-groups-tmdx-buy-rating-reiterated-at-td-cowen-2026-09-08/
TransMedics: Slowing Growth Brings Its Valuation Into Question
September 8, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4943749-transmedics-slowing-growth-brings-its-valuation-into-question
Did TransMedics Group, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
September 7, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/did-transmedics-group-inc-insiders-breach-their-fiduciary-duties-to-shareholders-302870917.html

New MarketBeat Followers Over Time

Media Sentiment Over Time

Enovis stock logo

Enovis NYSE:ENOV

$18.03 +0.23 (+1.29%)
Closing price 09/18/2026 03:59 PM Eastern
Extended Trading
$18.05 +0.02 (+0.09%)
As of 09/18/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.

iRadimed stock logo

iRadimed NASDAQ:IRMD

$82.12 -0.62 (-0.75%)
Closing price 09/18/2026 04:00 PM Eastern
Extended Trading
$82.15 +0.03 (+0.04%)
As of 09/18/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.

Soleno Therapeutics stock logo

Soleno Therapeutics NASDAQ:SLNO

Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Extended-Release tablets, a once-daily oral tablet, which is in Phase III clinical trials for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is based in Redwood City, California.

TransMedics Group stock logo

TransMedics Group NASDAQ:TMDX

$86.42 -0.24 (-0.28%)
Closing price 09/18/2026 04:00 PM Eastern
Extended Trading
$87.75 +1.33 (+1.54%)
As of 09/18/2026 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas